The global chronic wound care market was valued at USD 12.8 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.07% from 2023 to 2030. Increasing incidences of sports injuries, increasing prevalence of diabetes, and changing lifestyles are anticipated to drive market growth.
Increasing incidences of chronic diseases such as diabetes, cancer, and other autoimmune diseases are anticipated to increase the incidence rate of chronic wounds across the globe. Antimicrobial resistance, unhealthy & sedentary lifestyles, and tobacco & alcohol consumption are contributing to the rising prevalence of non-communicable diseases. For instance, according to the CDC’s National Diabetes Statistics report of 2020, the number of diabetes patients has increased to an estimated 34.2 million, which comprises about 10.5% of the total population. According to a similar report, an estimated 26.8 million people have been diagnosed with diabetes, whereas 7.3 million people had diabetes and were yet to be diagnosed.
The COVID-19 pandemic has positively impacted the healthcare industry, with an increase in demand for medical tapes and bandages, which is anticipated to drive the market over the forecast period. The pandemic has increased the demand for drug delivery products, diagnostic & laboratory disposables, respiratory supplies, sterilization supplies, apparel, and hand sanitizers. Moreover, rising awareness among customers regarding the benefits of cleanliness and hygiene is anticipated to boost the market for sterilization supplies, apparel, and hand sanitizers over the forecast period.
The rising prevalence of obesity is another key factor likely to drive market growth, as it is associated with chronic wounds and lower extremity amputations. Obese people are at a higher risk of pressure ulcers, with reduced vascular activity in adipose tissue. The incapability of these patients to reposition themselves in bed acts as a precursor for pressure-related injuries. Furthermore, the skin folds on their bodies provide ideal conditions for microorganisms to thrive. Ulcers are caused by the breakdown of skin caused by these microorganisms. Thus, are most likely to boost demand for these products, leading to market growth.
Advanced wound dressing dominated the product segment of the market with a market share of 35.00% in 2022 and is expected to witness the fastest growth over the forecast period due to an increase in technological advancement, rising cases of chronic diseases, and an increase in the number of sports-related injuries.
Based on products, the wound care market is segmented into traditional wound dressings, advanced wound dressings, surgical wound dressings, and wound therapy devices. The market is expected to witness significant growth owing to the increasing prevalence of chronic diseases such as diabetic foot ulcers and venous leg ulcers. Moreover, the rising geriatric population across the globe is also expected to boost the market growth. Increasing awareness of surgical site infection and rising disposable income are other major factors that are expected to foster market growth.
Foam dressing helps in absorbing the moisture that aids in maintaining the integrity of the tissue. The increasing cases of trauma and pressure ulcer patients across the globe are expected to propel the segment growth. For instance, as per the Agency for Healthcare Research and Quality, every year, more than 2.5 million people in the U.S. develop pressure ulcers. Foams are mainly used to protect skin breakdown due to friction, aiding chronic wound management and propelling the segment growth over the forecast period.
In 2022, based on end-use, the hospital segment accounted for the maximum revenue share with around 46.00% owing to the increasing number of surgeries, globally. However, the home healthcare segment is anticipated to witness the fastest growth rate of 4.90% during the forecast period due to the increase in demand for reduced hospital stays.
Increasing surgical procedures, rising incidence of diabetic foot ulcers, and an increasing number of hospitals are among the major factors driving the segment growth. As per the latest survey by the American Hospital Association, the total number of hospitals in the U.S. is estimated to be 6,093 in 2022. Similarly, as per reports, there has been a constant increase in the number of hospitals in the U.K., as the number of hospitals has increased to 1,978 in 2019. Thus, such factors may increase the number of surgeries, and therefore may surge the segment growth over the forecast period.
Wound care in homecare settings was majorly initiated with the introduction of single-use NPWT systems. These devices are lightweight, portable, canister-free, and easy to use. In addition, the cost-effectiveness of such therapy for treating wounds also encourages patients to adopt homecare settings over hospital stays.
Based on application, the diabetic foot ulcers segment dominated the market in 2022 with a market share of 35.00%. This can be attributed to the increase in the number of diabetic patients globally. However, the pressure ulcers segment is anticipated to witness the fastest growth over the forecast period owing to the increasing prevalence of obesity and related wounds.
Pressure ulcers are injuries to the skin and underlying tissues, which are a result of prolonged pressure on the skin. This can be caused due to prolonged hospitalization and being unable to move, which especially happens in old age and in case of sudden weight loss. For instance, according to Agency for Healthcare Research and Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year. Similarly, according to NCBI, the incidence of pressure ulcers in a clinical setting may range from 4.0% to 38.0%. In addition, according to a similar source, the mortality rate due to pressure ulcers and associated disorders is estimated to be approximately 68.0% in adults. As the geriatric population is more vulnerable to pressure ulcers, an increase in the geriatric population may lead to a rise in the number of pressure ulcer patients, which is expected to propel segment growth over the forecast period.
North America was identified as the most revenue-generating region in 2022 with over 45.05% share of the chronic wound care market. Increasing sports injuries, road accidents, and the presence of several key players in the region are anticipated to drive the market in North America. For instance, as per the National Institute of Diabetes and Digestive Kidney Diseases, an estimated 34.2 million people have diabetes, which comprises 10.5% of the U.S. Additionally, 88 million adults people aged 18 years & older have prediabetes, which may further increase the chronic diseases in this region. Similarly, the availability of skilled professionals, improvement in healthcare infrastructure, and presence of major market players are also expected to drive the market over the forecast period.
Asia Pacific wound care market is anticipated to witness the fastest growth over the forecast period. The presence of developing countries such as China, India, and Japan is anticipated to boost market growth in the Asia Pacific region. In addition, with a rapidly aging population in this region, along with an increasing number of obese and diabetic patients, the use of chronic wounds in this region is anticipated to increase. Moreover, medical tourism in this region has also been attributed to the increase in demand for chronic wound care products.
The rising geriatric population is one of the major driving factors for the market growth in Japan. According to Europa, more than one in four people are above 65 years of age. As the geriatric population is at a higher risk of various diseases and disabilities, an increase in the elderly population may propel the demand for wound care products.
The market players are adopting various strategies, such as mergers & acquisitions, partnerships, and product launches to strengthen their foothold in the market. Moreover, the key companies are investing heavily in research and development to launch new, innovative, and technologically advanced products in the market. Some of the key market players in the global chronic wound care market are:
JOHNSON & JOHNSON
Medline Industries, Inc.
ConvaTec Group PLC
Derma Sciences (Integra LifeSciences)
Mölnlycke Health Care AB
Paul Hartmann AG
Smith & Nephew PLC
Market size value in 2023
USD 13.3 billion
Revenue forecast in 2030
USD 17.6 billion
CAGR of 4.07% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD Million and CAGR from 2023 to 2030
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Product, application, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; South Korea; Australia; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE
Key companies profiled
Johnson & Johnson; Baxter International; Coloplast Corp.; 3M; Medline Industries, Inc.; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Mölnlycke Health Care AB; Paul Hartmann AG; Smith & Nephew PLC
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global chronic wound care market report based on products, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Advanced Wound Dressing
Surgical Wound Care
Suture & Staples
Tissue Adhesive & Sealants
Traditional Wound Care
Wound Therapy Devices
Negative Pressure Wound Therapy
Oxygen and Hyperbaric Oxygen Equipment
Electric Stimulation Devices
Pressure Relief Devices
Application Outlook (Revenue, USD Million, 2018 - 2030)
Diabetic Foot Ulcers
Venous Leg Ulcers
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
b. The global chronic wound care market size was estimated at USD 12.8 billion in 2021 and is expected to reach USD 12.82 billion in 2022.
b. The global chronic wound care market is expected to grow at a compound annual growth rate of 4.1% from 2023 to 2030 to reach USD 17.6 billion by 2030
b. Advanced wound dressing dominated the product segment of the chronic wound care market with a market share of 35.00% in 2022. This is attributable to an increase in technological advancement, rising cases of chronic diseases, and an increase in the number of sports-related injuries
b. The key players operating in the chronic wound care market include Johnson & Johnson, Baxter International, Coloplast Corp., 3M, Medline Industries, Inc., ConvaTec Group PLC, Derma Sciences (Integra LifeSciences), Mölnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew PLC.
b. Increasing incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is anticipated to boost the chronic wounds care market across the globe
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."